Our data suggest a role for both IDO1 and IL4I1 in high-grade serous ovarian cancer and indicate that IL4I1 may be involved in progression of the disease through metabolism of Phe and Tyr. Here, IL4I1 is linked to ovarian serous adenocarcinoma.